| Financial Year |
March 31 2023 |
| Monetary Funds |
1,780,814,112.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,804,946,454.67 |
| Advances to Suppliers |
120,833,998.40 |
| Other Receivables |
64,733,433.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
29,400,000.00 |
| Inventories |
1,137,415,816.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
711,471,319.47 |
| Total Current Assets |
5,962,347,265.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,158,504,399.24 |
| Investment Properties |
-- |
| Fixed Assetes |
531,479,136.55 |
| Under-construction Projects |
45,841,642.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,336,570,214.28 |
| R&D expenses |
-- |
| Goodwill |
10,744,819.35 |
| Long-Term Deferred and Prepaid Expenses |
6,375,714.01 |
| Deferred Income Tax Assets |
118,807,653.93 |
| Other Non-Current Assets |
26,364,593.22 |
| Sub-Total of Non-Current Assets |
18,248,598,111.62 |
| Total Assets |
24,210,945,377.12 |
| Short-Term Loans |
37,744,097.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,086,818,285.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,197,158.79 |
| Taxes Payable |
98,627,186.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
124,965,801.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
547,084,989.75 |
| Other Current Liabilities |
228,184,991.05 |
| Sub-Total of Current Liabilities |
4,697,889,280.31 |
| Long-term Loans |
7,080,450,959.53 |
| Bonds Payable |
1,000,384,126.13 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
710,958,209.73 |
| Deferred Income Tax Liabilities |
8,419,619.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,870,383,542.77 |
| Total Liabilities |
13,568,272,823.08 |
| Paid-In Capital(Or Share Stock) |
1,678,268,000.00 |
| Capital Surplus |
4,041,507,433.19 |
| Surplus Reserve |
255,928,760.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,986,734,770.82 |
| Minority Stockholder's Interest |
641,659,942.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,001,012,611.55 |
| Owner's Equity（Stockholder's Equity） |
10,642,672,554.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,210,945,377.12 |
